| 1 | prophylactic | 6,020 |
| 2 | broad-spectrum | 680 |
| 3 | macrolide | 492 |
| 4 | beta-lactam | 393 |
| 5 | β-lactam | 91 |
| 6 | peroral | 88 |
| 7 | non-opioid | 86 |
| 8 | direct-acting | 84 |
| 9 | plasmid-mediated | 55 |
| 10 | prime-boost | 54 |
| 11 | nonopioid | 51 |
| 12 | antipseudomonal | 47 |
| 13 | narrow-spectrum | 38 |
| 14 | ketolide | 35 |
| 15 | cephamycin | 32 |
| 16 | anti-pseudomonal | 31 |
| 17 | procalcitonin-guided | 28 |
| 18 | anti-staphylococcal | 27 |
| 19 | non-absorbed | 27 |
| 20 | nonlatex | 26 |
| 21 | betalactam | 25 |
| 22 | rapid-onset | 25 |
| 23 | monobactam | 24 |
| 24 | lipopeptide | 23 |
| 25 | wide-spectrum | 22 |
| 26 | non-carbapenem | 21 |
| 27 | antichlamydial | 20 |
| 28 | nonsystemic | 19 |
| 29 | nonbenzodiazepine | 17 |
| 30 | pct-guided | 17 |
| 31 | in-feed | 16 |
| 32 | second-choice | 15 |
| 33 | non-curative | 14 |
| 34 | zinc-containing | 14 |
| 35 | non-quinolone | 12 |
| 36 | de-escalating | 10 |
| 37 | leftover | 10 |
| 38 | non-artemisinin | 10 |
| 39 | beta-lactamase-resistant | 9 |
| 40 | cholesterol-modifying | 9 |
| 41 | ototopical | 9 |
| 42 | perindopril-based | 9 |
| 43 | 4-quinolone | 8 |
| 44 | hsp-based | 8 |
| 45 | non-nephrotoxic | 8 |
| 46 | broader-spectrum | 7 |
| 47 | lactobacillus-based | 7 |
| 48 | neuroprotector | 7 |
| 49 | prime/boost | 7 |
| 50 | aminoglucoside | 6 |
| 51 | bulk-forming | 6 |
| 52 | fluoroquinolone-sparing | 6 |
| 53 | non-cdi-related | 6 |
| 54 | non-β-lactam | 6 |
| 55 | opioid-containing | 6 |
| 56 | evaluation-outcome | 5 |
| 57 | late-generation | 5 |
| 58 | oxacephem | 5 |
| 59 | penicillinase-resistant | 5 |
| 60 | underarm | 5 |
| 61 | 10-14-day | 4 |
| 62 | aminocyclitol | 4 |
| 63 | carbamylating | 4 |
| 64 | central-acting | 4 |
| 65 | cns-penetrating | 4 |
| 66 | ed-administered | 4 |
| 67 | non-beta-lactam | 4 |
| 68 | non-fluoroquinolone | 4 |
| 69 | non-injectable | 4 |
| 70 | non-tramadol | 4 |
| 71 | 0.25-mm | 3 |
| 72 | 16-g/m2 | 3 |
| 73 | anti-legionella | 3 |
| 74 | antipseudomonas | 3 |
| 75 | biofilm-disrupting | 3 |
| 76 | high-efficacy | 3 |
| 77 | host-targeting | 3 |
| 78 | local-delivery | 3 |
| 79 | low-spectrum | 3 |
| 80 | multicategory | 3 |
| 81 | non-antitumour | 3 |
| 82 | parentral | 3 |
| 83 | pre-turp | 3 |
| 84 | prophylatic | 3 |
| 85 | quinolone-based | 3 |
| 86 | soft-solid | 3 |
| 87 | 'pharmacological | 2 |
| 88 | 0.15-mm | 2 |
| 89 | 35-g/m2 | 2 |
| 90 | 5-valent | 2 |
| 91 | anthranoid | 2 |
| 92 | anti-hsv1 | 2 |
| 93 | antipseudomonadal | 2 |
| 94 | antistaphylococal | 2 |
| 95 | broadspectrum | 2 |
| 96 | cefem | 2 |
| 97 | ciprofloxacin-containing | 2 |
| 98 | comparer | 2 |
| 99 | four-stroke | 2 |
| 100 | glutamine-containing | 2 |
| 101 | haemorrhages.amino-cerv | 2 |
| 102 | he-induced | 2 |
| 103 | left-over | 2 |
| 104 | low-equipotency | 2 |
| 105 | mbp+oral | 2 |
| 106 | neuromodulative | 2 |
| 107 | nichd-funded | 2 |
| 108 | nitro-imidazole | 2 |
| 109 | non-macrolide | 2 |
| 110 | non-prophylactic | 2 |
| 111 | noncatecholamine | 2 |
| 112 | nonlicensed | 2 |
| 113 | oxygen+oral | 2 |
| 114 | penicillin-based | 2 |
| 115 | peritreatment | 2 |
| 116 | phmb-based | 2 |
| 117 | pleuromutilin | 2 |
| 118 | proct-guided | 2 |
| 119 | prolonged-use | 2 |
| 120 | pth-like | 2 |
| 121 | third-choice | 2 |
| 122 | uti-specific | 2 |
| 123 | 'impure | 1 |
| 124 | 'orthopedic | 1 |
| 125 | 'thiazide | 1 |
| 126 | -spectrum | 1 |
| 127 | 1-oxacephem | 1 |
| 128 | 10-cm-long | 1 |
| 129 | 125-cm3 | 1 |
| 130 | 50-cm3 | 1 |
| 131 | 8-methoxy-fluoroquinolone | 1 |
| 132 | acyl-chain | 1 |
| 133 | agonist-formed | 1 |
| 134 | anti-rgm | 1 |
| 135 | antiseptic/ | 1 |
| 136 | appyling | 1 |
| 137 | arylfluoroquinolone | 1 |
| 138 | azide-functionalized | 1 |
| 139 | benzimidazole-class | 1 |
| 140 | beta-actam | 1 |
| 141 | broad-coverage | 1 |
| 142 | bronchoscopy-guided | 1 |
| 143 | bupivacaine-based | 1 |
| 144 | bêta-lactam | 1 |
| 145 | cds/crp-guided | 1 |
| 146 | cephalospolin | 1 |
| 147 | chephamycin | 1 |
| 148 | cp/chronic | 1 |
| 149 | curcumin-photodynamic | 1 |
| 150 | cylinder-capacity | 1 |
| 151 | deescalating | 1 |
| 152 | delayed/inappropriate | 1 |
| 153 | diphenolic | 1 |
| 154 | dithiolopyrrolone | 1 |
| 155 | ee-containing | 1 |
| 156 | england.prophylactic | 1 |
| 157 | evernimicin | 1 |
| 158 | existint | 1 |
| 159 | first-dose-loading | 1 |
| 160 | fuel-injection | 1 |
| 161 | gastrointestinal-selective | 1 |
| 162 | gut-targeted | 1 |
| 163 | hamed | 1 |
| 164 | high-spf | 1 |
| 165 | i.e.intubating | 1 |
| 166 | infections.once-daily | 1 |
| 167 | irct138904014236n1 | 1 |
| 168 | irf3/ifnβ-dependent | 1 |
| 169 | isocentric | 1 |
| 170 | m2e-specific | 1 |
| 171 | market-existing | 1 |
| 172 | medihoney | 1 |
| 173 | months-long | 1 |
| 174 | more-targeted | 1 |
| 175 | mrsa-active | 1 |
| 176 | msbp-based | 1 |
| 177 | multidosed | 1 |
| 178 | nitrotyrosylated | 1 |
| 179 | no/nitrosothiol-mediated | 1 |
| 180 | non-antipseudomonal | 1 |
| 181 | non-insulated | 1 |
| 182 | non-replaceable | 1 |
| 183 | nonbacteriolytic | 1 |
| 184 | noncephalosporin | 1 |
| 185 | nonneedle | 1 |
| 186 | nonwatertight | 1 |
| 187 | oral/transdermal | 1 |
| 188 | oxa-beta-lactam | 1 |
| 189 | oxazolidinone-type | 1 |
| 190 | panaceal | 1 |
| 191 | par-1-mediated | 1 |
| 192 | pharmacologically-improved | 1 |
| 193 | pivoxilsulbactam-containing | 1 |
| 194 | poor-fitting | 1 |
| 195 | postnausea | 1 |
| 196 | prolonged-course | 1 |
| 197 | prophylactic/suppressive | 1 |
| 198 | propylactic | 1 |
| 199 | pulmanex | 1 |
| 200 | pulse-dosed | 1 |
| 201 | rapidly-effective | 1 |
| 202 | rates.delayed | 1 |
| 203 | rehabilitation.spinal | 1 |
| 204 | relocatable | 1 |
| 205 | salinic | 1 |
| 206 | self-started | 1 |
| 207 | strong-acting | 1 |
| 208 | sub-peritoneal | 1 |
| 209 | suturable | 1 |
| 210 | thc-based | 1 |
| 211 | thromboxane-dependent | 1 |
| 212 | thromboxane-induced | 1 |
| 213 | treatment-dose | 1 |
| 214 | twice-annual | 1 |
| 215 | us-produced | 1 |
| 216 | usually-chosen | 1 |
| 217 | vaccinees:92 | 1 |
| 218 | visa-mediated | 1 |
| 219 | β-lactam-based | 1 |
| 1 | 'impure | 1 |
| 2 | 'orthopedic | 1 |
| 3 | 'pharmacological | 2 |
| 4 | 'thiazide | 1 |
| 5 | -spectrum | 1 |
| 6 | 0.15-mm | 2 |
| 7 | 0.25-mm | 3 |
| 8 | 1-oxacephem | 1 |
| 9 | 10-14-day | 4 |
| 10 | 10-cm-long | 1 |
| 11 | 125-cm3 | 1 |
| 12 | 16-g/m2 | 3 |
| 13 | 35-g/m2 | 2 |
| 14 | 4-quinolone | 8 |
| 15 | 5-valent | 2 |
| 16 | 50-cm3 | 1 |
| 17 | 8-methoxy-fluoroquinolone | 1 |
| 18 | acyl-chain | 1 |
| 19 | agonist-formed | 1 |
| 20 | aminocyclitol | 4 |
| 21 | aminoglucoside | 6 |
| 22 | anthranoid | 2 |
| 23 | anti-hsv1 | 2 |
| 24 | anti-legionella | 3 |
| 25 | anti-pseudomonal | 31 |
| 26 | anti-rgm | 1 |
| 27 | anti-staphylococcal | 27 |
| 28 | antichlamydial | 20 |
| 29 | antipseudomonadal | 2 |
| 30 | antipseudomonal | 47 |
| 31 | antipseudomonas | 3 |
| 32 | antiseptic/ | 1 |
| 33 | antistaphylococal | 2 |
| 34 | appyling | 1 |
| 35 | arylfluoroquinolone | 1 |
| 36 | azide-functionalized | 1 |
| 37 | benzimidazole-class | 1 |
| 38 | beta-actam | 1 |
| 39 | beta-lactam | 393 |
| 40 | beta-lactamase-resistant | 9 |
| 41 | betalactam | 25 |
| 42 | biofilm-disrupting | 3 |
| 43 | broad-coverage | 1 |
| 44 | broad-spectrum | 680 |
| 45 | broader-spectrum | 7 |
| 46 | broadspectrum | 2 |
| 47 | bronchoscopy-guided | 1 |
| 48 | bulk-forming | 6 |
| 49 | bupivacaine-based | 1 |
| 50 | bêta-lactam | 1 |
| 51 | carbamylating | 4 |
| 52 | cds/crp-guided | 1 |
| 53 | cefem | 2 |
| 54 | central-acting | 4 |
| 55 | cephalospolin | 1 |
| 56 | cephamycin | 32 |
| 57 | chephamycin | 1 |
| 58 | cholesterol-modifying | 9 |
| 59 | ciprofloxacin-containing | 2 |
| 60 | cns-penetrating | 4 |
| 61 | comparer | 2 |
| 62 | cp/chronic | 1 |
| 63 | curcumin-photodynamic | 1 |
| 64 | cylinder-capacity | 1 |
| 65 | de-escalating | 10 |
| 66 | deescalating | 1 |
| 67 | delayed/inappropriate | 1 |
| 68 | diphenolic | 1 |
| 69 | direct-acting | 84 |
| 70 | dithiolopyrrolone | 1 |
| 71 | ed-administered | 4 |
| 72 | ee-containing | 1 |
| 73 | england.prophylactic | 1 |
| 74 | evaluation-outcome | 5 |
| 75 | evernimicin | 1 |
| 76 | existint | 1 |
| 77 | first-dose-loading | 1 |
| 78 | fluoroquinolone-sparing | 6 |
| 79 | four-stroke | 2 |
| 80 | fuel-injection | 1 |
| 81 | gastrointestinal-selective | 1 |
| 82 | glutamine-containing | 2 |
| 83 | gut-targeted | 1 |
| 84 | haemorrhages.amino-cerv | 2 |
| 85 | hamed | 1 |
| 86 | he-induced | 2 |
| 87 | high-efficacy | 3 |
| 88 | high-spf | 1 |
| 89 | host-targeting | 3 |
| 90 | hsp-based | 8 |
| 91 | i.e.intubating | 1 |
| 92 | in-feed | 16 |
| 93 | infections.once-daily | 1 |
| 94 | irct138904014236n1 | 1 |
| 95 | irf3/ifnβ-dependent | 1 |
| 96 | isocentric | 1 |
| 97 | ketolide | 35 |
| 98 | lactobacillus-based | 7 |
| 99 | late-generation | 5 |
| 100 | left-over | 2 |
| 101 | leftover | 10 |
| 102 | lipopeptide | 23 |
| 103 | local-delivery | 3 |
| 104 | low-equipotency | 2 |
| 105 | low-spectrum | 3 |
| 106 | m2e-specific | 1 |
| 107 | macrolide | 492 |
| 108 | market-existing | 1 |
| 109 | mbp+oral | 2 |
| 110 | medihoney | 1 |
| 111 | monobactam | 24 |
| 112 | months-long | 1 |
| 113 | more-targeted | 1 |
| 114 | mrsa-active | 1 |
| 115 | msbp-based | 1 |
| 116 | multicategory | 3 |
| 117 | multidosed | 1 |
| 118 | narrow-spectrum | 38 |
| 119 | neuromodulative | 2 |
| 120 | neuroprotector | 7 |
| 121 | nichd-funded | 2 |
| 122 | nitro-imidazole | 2 |
| 123 | nitrotyrosylated | 1 |
| 124 | no/nitrosothiol-mediated | 1 |
| 125 | non-absorbed | 27 |
| 126 | non-antipseudomonal | 1 |
| 127 | non-antitumour | 3 |
| 128 | non-artemisinin | 10 |
| 129 | non-beta-lactam | 4 |
| 130 | non-carbapenem | 21 |
| 131 | non-cdi-related | 6 |
| 132 | non-curative | 14 |
| 133 | non-fluoroquinolone | 4 |
| 134 | non-injectable | 4 |
| 135 | non-insulated | 1 |
| 136 | non-macrolide | 2 |
| 137 | non-nephrotoxic | 8 |
| 138 | non-opioid | 86 |
| 139 | non-prophylactic | 2 |
| 140 | non-quinolone | 12 |
| 141 | non-replaceable | 1 |
| 142 | non-tramadol | 4 |
| 143 | non-β-lactam | 6 |
| 144 | nonbacteriolytic | 1 |
| 145 | nonbenzodiazepine | 17 |
| 146 | noncatecholamine | 2 |
| 147 | noncephalosporin | 1 |
| 148 | nonlatex | 26 |
| 149 | nonlicensed | 2 |
| 150 | nonneedle | 1 |
| 151 | nonopioid | 51 |
| 152 | nonsystemic | 19 |
| 153 | nonwatertight | 1 |
| 154 | opioid-containing | 6 |
| 155 | oral/transdermal | 1 |
| 156 | ototopical | 9 |
| 157 | oxa-beta-lactam | 1 |
| 158 | oxacephem | 5 |
| 159 | oxazolidinone-type | 1 |
| 160 | oxygen+oral | 2 |
| 161 | panaceal | 1 |
| 162 | par-1-mediated | 1 |
| 163 | parentral | 3 |
| 164 | pct-guided | 17 |
| 165 | penicillin-based | 2 |
| 166 | penicillinase-resistant | 5 |
| 167 | perindopril-based | 9 |
| 168 | peritreatment | 2 |
| 169 | peroral | 88 |
| 170 | pharmacologically-improved | 1 |
| 171 | phmb-based | 2 |
| 172 | pivoxilsulbactam-containing | 1 |
| 173 | plasmid-mediated | 55 |
| 174 | pleuromutilin | 2 |
| 175 | poor-fitting | 1 |
| 176 | postnausea | 1 |
| 177 | pre-turp | 3 |
| 178 | prime-boost | 54 |
| 179 | prime/boost | 7 |
| 180 | procalcitonin-guided | 28 |
| 181 | proct-guided | 2 |
| 182 | prolonged-course | 1 |
| 183 | prolonged-use | 2 |
| 184 | prophylactic | 6,020 |
| 185 | prophylactic/suppressive | 1 |
| 186 | prophylatic | 3 |
| 187 | propylactic | 1 |
| 188 | pth-like | 2 |
| 189 | pulmanex | 1 |
| 190 | pulse-dosed | 1 |
| 191 | quinolone-based | 3 |
| 192 | rapid-onset | 25 |
| 193 | rapidly-effective | 1 |
| 194 | rates.delayed | 1 |
| 195 | rehabilitation.spinal | 1 |
| 196 | relocatable | 1 |
| 197 | salinic | 1 |
| 198 | second-choice | 15 |
| 199 | self-started | 1 |
| 200 | soft-solid | 3 |
| 201 | strong-acting | 1 |
| 202 | sub-peritoneal | 1 |
| 203 | suturable | 1 |
| 204 | thc-based | 1 |
| 205 | third-choice | 2 |
| 206 | thromboxane-dependent | 1 |
| 207 | thromboxane-induced | 1 |
| 208 | treatment-dose | 1 |
| 209 | twice-annual | 1 |
| 210 | underarm | 5 |
| 211 | us-produced | 1 |
| 212 | usually-chosen | 1 |
| 213 | uti-specific | 2 |
| 214 | vaccinees:92 | 1 |
| 215 | visa-mediated | 1 |
| 216 | wide-spectrum | 22 |
| 217 | zinc-containing | 14 |
| 218 | β-lactam | 91 |
| 219 | β-lactam-based | 1 |
| 1 | antiseptic/ | 1 |
| 2 | irct138904014236n1 | 1 |
| 3 | anti-hsv1 | 2 |
| 4 | vaccinees:92 | 1 |
| 5 | 35-g/m2 | 2 |
| 6 | 16-g/m2 | 3 |
| 7 | 50-cm3 | 1 |
| 8 | 125-cm3 | 1 |
| 9 | postnausea | 1 |
| 10 | anti-legionella | 3 |
| 11 | 'orthopedic | 1 |
| 12 | m2e-specific | 1 |
| 13 | uti-specific | 2 |
| 14 | diphenolic | 1 |
| 15 | curcumin-photodynamic | 1 |
| 16 | nonsystemic | 19 |
| 17 | salinic | 1 |
| 18 | cp/chronic | 1 |
| 19 | isocentric | 1 |
| 20 | prophylatic | 3 |
| 21 | prophylactic | 6,020 |
| 22 | non-prophylactic | 2 |
| 23 | england.prophylactic | 1 |
| 24 | propylactic | 1 |
| 25 | nonbacteriolytic | 1 |
| 26 | non-nephrotoxic | 8 |
| 27 | non-absorbed | 27 |
| 28 | he-induced | 2 |
| 29 | thromboxane-induced | 1 |
| 30 | us-produced | 1 |
| 31 | procalcitonin-guided | 28 |
| 32 | cds/crp-guided | 1 |
| 33 | proct-guided | 2 |
| 34 | pct-guided | 17 |
| 35 | bronchoscopy-guided | 1 |
| 36 | nichd-funded | 2 |
| 37 | in-feed | 16 |
| 38 | hamed | 1 |
| 39 | agonist-formed | 1 |
| 40 | ed-administered | 4 |
| 41 | phmb-based | 2 |
| 42 | thc-based | 1 |
| 43 | bupivacaine-based | 1 |
| 44 | quinolone-based | 3 |
| 45 | perindopril-based | 9 |
| 46 | β-lactam-based | 1 |
| 47 | penicillin-based | 2 |
| 48 | msbp-based | 1 |
| 49 | hsp-based | 8 |
| 50 | lactobacillus-based | 7 |
| 51 | nonlicensed | 2 |
| 52 | pulse-dosed | 1 |
| 53 | multidosed | 1 |
| 54 | par-1-mediated | 1 |
| 55 | visa-mediated | 1 |
| 56 | plasmid-mediated | 55 |
| 57 | no/nitrosothiol-mediated | 1 |
| 58 | non-cdi-related | 6 |
| 59 | non-insulated | 1 |
| 60 | nitrotyrosylated | 1 |
| 61 | more-targeted | 1 |
| 62 | gut-targeted | 1 |
| 63 | self-started | 1 |
| 64 | pharmacologically-improved | 1 |
| 65 | rates.delayed | 1 |
| 66 | azide-functionalized | 1 |
| 67 | soft-solid | 3 |
| 68 | non-opioid | 86 |
| 69 | nonopioid | 51 |
| 70 | anthranoid | 2 |
| 71 | second-choice | 15 |
| 72 | third-choice | 2 |
| 73 | macrolide | 492 |
| 74 | non-macrolide | 2 |
| 75 | ketolide | 35 |
| 76 | aminoglucoside | 6 |
| 77 | lipopeptide | 23 |
| 78 | 'thiazide | 1 |
| 79 | broad-coverage | 1 |
| 80 | pth-like | 2 |
| 81 | four-stroke | 2 |
| 82 | non-replaceable | 1 |
| 83 | suturable | 1 |
| 84 | relocatable | 1 |
| 85 | non-injectable | 4 |
| 86 | nonneedle | 1 |
| 87 | nitro-imidazole | 2 |
| 88 | evaluation-outcome | 5 |
| 89 | noncatecholamine | 2 |
| 90 | nonbenzodiazepine | 17 |
| 91 | 4-quinolone | 8 |
| 92 | non-quinolone | 12 |
| 93 | non-fluoroquinolone | 4 |
| 94 | 8-methoxy-fluoroquinolone | 1 |
| 95 | arylfluoroquinolone | 1 |
| 96 | dithiolopyrrolone | 1 |
| 97 | oxazolidinone-type | 1 |
| 98 | 'impure | 1 |
| 99 | treatment-dose | 1 |
| 100 | prolonged-course | 1 |
| 101 | prolonged-use | 2 |
| 102 | delayed/inappropriate | 1 |
| 103 | prophylactic/suppressive | 1 |
| 104 | neuromodulative | 2 |
| 105 | non-curative | 14 |
| 106 | mrsa-active | 1 |
| 107 | rapidly-effective | 1 |
| 108 | gastrointestinal-selective | 1 |
| 109 | high-spf | 1 |
| 110 | first-dose-loading | 1 |
| 111 | appyling | 1 |
| 112 | bulk-forming | 6 |
| 113 | zinc-containing | 14 |
| 114 | opioid-containing | 6 |
| 115 | ee-containing | 1 |
| 116 | glutamine-containing | 2 |
| 117 | pivoxilsulbactam-containing | 1 |
| 118 | ciprofloxacin-containing | 2 |
| 119 | fluoroquinolone-sparing | 6 |
| 120 | i.e.intubating | 1 |
| 121 | de-escalating | 10 |
| 122 | deescalating | 1 |
| 123 | carbamylating | 4 |
| 124 | cns-penetrating | 4 |
| 125 | strong-acting | 1 |
| 126 | central-acting | 4 |
| 127 | direct-acting | 84 |
| 128 | host-targeting | 3 |
| 129 | biofilm-disrupting | 3 |
| 130 | market-existing | 1 |
| 131 | poor-fitting | 1 |
| 132 | cholesterol-modifying | 9 |
| 133 | 10-cm-long | 1 |
| 134 | months-long | 1 |
| 135 | anti-staphylococcal | 27 |
| 136 | 'pharmacological | 2 |
| 137 | ototopical | 9 |
| 138 | antistaphylococal | 2 |
| 139 | antipseudomonadal | 2 |
| 140 | panaceal | 1 |
| 141 | sub-peritoneal | 1 |
| 142 | antichlamydial | 20 |
| 143 | oral/transdermal | 1 |
| 144 | rehabilitation.spinal | 1 |
| 145 | anti-pseudomonal | 31 |
| 146 | antipseudomonal | 47 |
| 147 | non-antipseudomonal | 1 |
| 148 | oxygen+oral | 2 |
| 149 | mbp+oral | 2 |
| 150 | peroral | 88 |
| 151 | parentral | 3 |
| 152 | twice-annual | 1 |
| 153 | non-tramadol | 4 |
| 154 | aminocyclitol | 4 |
| 155 | beta-actam | 1 |
| 156 | monobactam | 24 |
| 157 | beta-lactam | 393 |
| 158 | oxa-beta-lactam | 1 |
| 159 | non-beta-lactam | 4 |
| 160 | bêta-lactam | 1 |
| 161 | β-lactam | 91 |
| 162 | non-β-lactam | 6 |
| 163 | betalactam | 25 |
| 164 | cefem | 2 |
| 165 | oxacephem | 5 |
| 166 | 1-oxacephem | 1 |
| 167 | non-carbapenem | 21 |
| 168 | anti-rgm | 1 |
| 169 | 0.15-mm | 2 |
| 170 | 0.25-mm | 3 |
| 171 | underarm | 5 |
| 172 | -spectrum | 1 |
| 173 | broad-spectrum | 680 |
| 174 | wide-spectrum | 22 |
| 175 | broader-spectrum | 7 |
| 176 | low-spectrum | 3 |
| 177 | narrow-spectrum | 38 |
| 178 | broadspectrum | 2 |
| 179 | usually-chosen | 1 |
| 180 | acyl-chain | 1 |
| 181 | evernimicin | 1 |
| 182 | cephamycin | 32 |
| 183 | chephamycin | 1 |
| 184 | pleuromutilin | 2 |
| 185 | cephalospolin | 1 |
| 186 | non-artemisinin | 10 |
| 187 | noncephalosporin | 1 |
| 188 | late-generation | 5 |
| 189 | fuel-injection | 1 |
| 190 | pre-turp | 3 |
| 191 | comparer | 2 |
| 192 | left-over | 2 |
| 193 | leftover | 10 |
| 194 | neuroprotector | 7 |
| 195 | non-antitumour | 3 |
| 196 | antipseudomonas | 3 |
| 197 | benzimidazole-class | 1 |
| 198 | rapid-onset | 25 |
| 199 | nonwatertight | 1 |
| 200 | beta-lactamase-resistant | 9 |
| 201 | penicillinase-resistant | 5 |
| 202 | thromboxane-dependent | 1 |
| 203 | irf3/ifnβ-dependent | 1 |
| 204 | 5-valent | 2 |
| 205 | peritreatment | 2 |
| 206 | existint | 1 |
| 207 | prime-boost | 54 |
| 208 | prime/boost | 7 |
| 209 | haemorrhages.amino-cerv | 2 |
| 210 | pulmanex | 1 |
| 211 | nonlatex | 26 |
| 212 | 10-14-day | 4 |
| 213 | high-efficacy | 3 |
| 214 | low-equipotency | 2 |
| 215 | medihoney | 1 |
| 216 | infections.once-daily | 1 |
| 217 | local-delivery | 3 |
| 218 | multicategory | 3 |
| 219 | cylinder-capacity | 1 |